Detalles de la búsqueda
1.
Quality of life, anxiety, depression, and distress in patients with advanced and metastatic lung cancer.
Palliat Support Care
; 21(4): 608-615, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36210754
2.
Clinical Impact of the COVID-19 Pandemic in Mexican Patients with Thoracic Malignancies.
Oncologist
; 26(12): 1035-1043, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34498780
3.
RRM1 and ERCC1 as biomarkers in patients with locally advanced and metastatic malignant pleural mesothelioma treated with continuous infusion of low-dose gemcitabine plus cisplatin.
BMC Cancer
; 21(1): 892, 2021 Aug 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34353292
4.
Brigatinib in ALK-positive non-small cell lung cancer: real-world data in the Latin American population (Bri-world extend CLICaP).
Future Oncol
; 17(2): 169-181, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32986959
5.
Cost-effectiveness analysis of first and second-generation EGFR tyrosine kinase inhibitors as first line of treatment for patients with NSCLC harboring EGFR mutations.
BMC Cancer
; 20(1): 829, 2020 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32873256
6.
A Patient With Newly Diagnosed, Advanced EGFR-Mutated Non-Small Cell Lung Cancer.
Oncology (Williston Park)
; 34(1): 21-27, 2020 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32645202
7.
Carboplatin plus etoposide or topotecan for small-cell lung cancer.
Lancet Oncol
; 21(9): 1132-1134, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32888446
8.
Impact of Concurrent Genomic Alterations on Clinical Outcomes in Patients With ALK-Rearranged NSCLC.
J Thorac Oncol
; 19(1): 119-129, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37572870
9.
Validation of a multiomic model of plasma extracellular vesicle PD-L1 and radiomics for prediction of response to immunotherapy in NSCLC.
J Exp Clin Cancer Res
; 43(1): 81, 2024 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38486328
10.
Case report: Osimertinib administration during pregnancy in a woman with advanced EGFR-mutant non-small cell lung cancer.
Front Oncol
; 13: 1108124, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37035182
11.
Liquid biopsy in clinical outcomes and detection of T790M mutation in metastatic non-small cell lung cancer after progression to EGFR-TKI.
Cancer Biomark
; 2023 Nov 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38108344
12.
Perilesional edema diameter associated with brain metastases as a predictive factor of response to radiotherapy in non-small cell lung cancer.
Front Oncol
; 13: 1251620, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37916162
13.
LKB1 Loss Assessed by Immunohistochemistry as a Prognostic Marker to First-Line Therapy in Advanced Non-Small-Cell Lung Cancer.
Curr Oncol
; 30(1): 333-343, 2022 12 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36661676
14.
Modifying factors of PD-L1 expression on tumor cells in advanced non-small-cell lung cancer.
Thorac Cancer
; 13(23): 3362-3373, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36317227
15.
A high number of co-occurring genomic alterations detected by NGS is associated with worse clinical outcomes in advanced EGFR-mutant lung adenocarcinoma: Data from LATAM population.
Lung Cancer
; 174: 133-140, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36379126
16.
Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer.
J Exp Clin Cancer Res
; 41(1): 186, 2022 Jun 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35650597
17.
Impact of detecting plasma EGFR mutations with ultrasensitive liquid biopsy in outcomes of NSCLC patients treated with first- or second-generation EGFR-TKIs.
Cancer Biomark
; 32(2): 123-135, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34057135
18.
Association of Lung Adenocarcinoma Subtypes According to the IASLC/ATS/ERS Classification and Programmed Cell Death Ligand 1 (PD-L1) Expression in Tumor Cells.
Pathol Oncol Res
; 27: 597499, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34257548
19.
Risk of development of brain metastases according to the IASLC/ATS/ERS lung adenocarcinoma classification in locally advanced and metastatic disease.
Lung Cancer
; 155: 183-190, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33558063
20.
Association of Carcinoembryonic Antigen Reduction With Progression-free and Overall Survival Improvement in Advanced Non-small-cell Lung Cancer.
Clin Lung Cancer
; 22(6): 510-522, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33947631